During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.
Discover the presentations of the prestigious interventionists that made part of this 13th edition...
For the thirteenth consecutive year, we will be hosting an educational excellence course for interventionalists in training from Latin America: the ProEducar-SOLACI Fellows Course.
This one-day...
During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.
Discover the presentations of the prestigious interventionists that made...
Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...
Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...
Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...